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Abstract: Ossabaw swine have a “thrifty genotype” and consumption of excess calories 
induces many classical components of the metabolic syndrome, including obesity, insulin 
resistance, impaired glucose tolerance, dyslipidemia, hyperleptinemia, and hypertension. Earlier 
studies indicate that the metabolic syndrome is associated with diminished cardiac function; 
however, to what degree this impairment is associated with alterations in myocardial β1- and 
β2-adrenoceptor (AR) expression has not been fully elucidated. Accordingly, the present study 
was designed to investigate the effects of the metabolic syndrome on cardiac β1- and β2-AR 
expression. Studies were conducted on left ventricular tissue samples obtained from control 
lean and chronically (50 weeks) high-fat-fed obese animals. Chronic feeding significantly 
increased fasting plasma insulin, total cholesterol, triglycerides, blood glucose, systolic 
and diastolic blood pressure, and heart rate. Real-time polymerase chain reaction revealed 
no significant alterations in cardiac β1- and β2-AR mRNA expression. In contrast, Western 
blot analysis revealed a significant decrease in ventricular β1- and β2-AR protein expression. 
This is the first report in a novel large animal model that induction of metabolic syndrome is 
accompanied by a significant reduction in cardiac β1- and β2-AR protein expression that could 
contribute to impaired cardiac function.
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Introduction
With the increasing burden of childhood obesity, the prevalence of metabolic syndrome 
in children still varies widely.1 However, using Adult Treatment Panel (ATP) III and 
World Health Organization criteria, a school-based study on metabolic syndrome has 
reported prevalence at 4.2% and 8.4%, respectively.1 Importantly, pediatric metabolic 
syndrome needs to be tracked very carefully from childhood to adulthood to prevent 
cardiometabolic risk.2 Metabolic syndrome is known to be associated with higher 
  cardiovascular mortality and morbidity, which is referred to as “cardiometabolic risk” 
in the clinics.3 Despite genetic and environmental factors, the key elements of metabolic 
syndrome are obesity, impaired glucose tolerance, insulin resistance, increased low-
density lipoprotein:high-density lipoprotein ratio, increased fasting and postprandial 
triglyceride levels, and hypertension.4 Specifically, centrally distributed adiposity in 
obesity strongly correlates with adult cardiometabolic risk.3
This multifaceted syndrome can result in a variety of cardiac and hemodynamic 
alterations that ultimately result in development of congestive heart failure.2,3 The 
mechanisms responsible for these disturbances are mainly multifactorial but could 
be related to a hyperdynamic circulatory state, which is characterized by increased International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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blood pressure, total blood volume, cardiac output, and tissue 
metabolic demand.5–7 Basal catecholamine level generally 
increases, a finding supported by many studies.6,8,9 Increased 
sympathetic system activity could stimulate G-protein-
coupled β-adrenoceptors (ARs), elevating intracellular 
cyclic adenosine monophosphate (cAMP), thereby activating 
protein kinase A (PKA) or calcium calmoduline kinase II 
(CaMKII).10–12 The duration of the disease is the key fac-
tor that attenuates β-AR-mediated cardiac responses and 
underlying mechanisms.
Determining the effects of metabolic syndrome on cardiac 
β-AR expression seems to be one of the novel therapeutic 
strategies against obesity-induced cardiometabolic risk. The 
author of this study determined hemodynamic parameters 
such as systolic, diastolic, and mean arterial blood pressures 
as well as heart rate. Real-time polymerase chain reaction 
(PCR) and Western blot analysis were used to assess mRNA 
and protein expressions in the left ventricles obtained from 
control and chronically (50 weeks) high-fat-fed animals. For 
that purpose, I selected obese Ossabaw swine, which are 
one of the novel large animals and the most similar model 
to human metabolic syndrome.
Methods
high-fat diet
This investigation was approved by the Indiana University 
School of Medicine Institutional Animal Care and Use 
  Committee and was conducted in accordance with the Guide 
for the Care and Use of Laboratory Animals. Ossabaw pigs 
were fed either a normal diet (Teklad, ∼13% calories from 
fat; n = 7) or a high-fat diet (∼60% of calories from fat; 
n = 9). The high-fat diet was administered in the morning 
and afternoon for ∼50 weeks. The pigs were maintained on 
this diet throughout the experimental protocol.
Analytical procedures
Plasma supernatant was collected and stored at −80°C.
Isolation and quantitation of total rnA
Left ventricles obtained from control and high-fat-fed 
Ossabaw swine. They were placed in liquid N2 and 
stored at −80°C. Total RNA was extracted according to 
manufacturer’s instructions (SV Total RNA Isolation 
System, Promega Corp, Fitchburg, WI). At the end of the 
isolation, RNA samples were dissolved in nuclease-free 
water (pH 7.5). The total RNA quantity and quality were 
determined using the   ExperionTM Semi-automated Elec-
trophoresis System (Bio-Rad Laboratories, Inc, Hercules, 
CA). In the Experion priming station, the microfluidic-based 
LabChip sample wells (RNA StdSens Chips, Experion, Bio-
Rad) were filled with a polymer-sieving matrix containing 
a fluorescent dye and 1 µL of denatured total RNA. The 
concentration of total RNA was determined by using the 
ratio of the sample RNA area to the Experion RNA ladder 
area. RNA samples with distinct 18S and 28S ribosomal 
RNA fragments in the electropherogram were used to assess 
RNA quality.
Preparation of first-strand cDNA via 
reverse transcriptase reactions
RNA samples were used as templates for synthesis of 
first-strand cDNAs as described previously. Briefly, 1 µL 
of oligo(dT)15 primer (Promega) was added to equivalent 
amounts of total RNA obtained from left ventricles isolated 
from control (n = 5) and chronically high-fat-fed (n = 5) 
pigs. The mixtures were then placed into a thermocycler 
(My CyclerTM, Bio-Rad) and held at 70°C for 5 minutes. 
The samples were then transferred into an ice bath for 
5 minutes to permit selective binding of the oligo(dT)15 
to the poly(A) tail of the mRNA. First-strand cDNA was 
then synthesized with an ImProm-II Reverse Transcriptase 
kit (Promega).8,17
Amplification of cDNA
Real-time PCR reactions were performed for β1-, β2-ARs, and 
β-actin in triplicate with a custom-designed SYBR® Green mix 
(2.4 µL of 25 mM MgCl2, 5 µL of 1:10,000 dilution SYBR 
Green I, Molecular Probes, Inc, Eugene, OR) and 5 µL of 1 nM 
fluorescein calibration dye (1 mM/L in dimethyl sulfoxide, 
Bio-Rad) in 50 µL of total reaction using Taq DNA polymerase 
(Promega).8,17 Primers were designed using the Genomatix 
Software Suite   program (Müchen, Germany) based on sequences 
published in the National Center for Biotechnology Informa-
tion   GenBank database.18 Gene-specific primers were used: 
for β1-ARs, sense 5′-GACCGAAAGCAGGTGAACTC-3′ 
and   antisense 5′-CTCCCATCCCTTCCCTAGTC-3′ (242 bp 
product; accession number AF042454); for β2-ARs, sense 
5′-GCCATCGACTGCTATCACAA-3′  and  antisense 
5′-GGTTTGGGGAGTGGAATCTT-3′ (193 bp product; 
accession number U53185); for β-actin, primers were designed 
based on published sequences in the GenBank database 
(sense 5′-ACGTGGACATCAGGAAGGAC-3′ and antisense 
5′-ACATCTGCTGGAAGGTGGAC-3′; accession number 
U07786).
Amplification was carried out with iCycler iQ multicolor 
real-time PCR detection system (Bio-Rad) as follows: International Journal of General Medicine 2011:4
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Figure 1 systolic BP, diastolic BP, and heart rate from lean and chronic high-fat-diet 
Ossabaw swine. Systolic and diastolic BPs and heart rate were significantly elevated in 
the metabolic syndrome group.
Note: aP , 0.05 versus control.
Abbreviations: BP, blood pressure; hr, heart rate.
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45-second denaturation (94°C) followed by 45-second 
annealing and 1-minute extension (72°C), repeated for 
a total of 40 cycles. β-actin was amplified in each set of 
PCR reactions and served as an internal reference during 
quantitation to correct for operator and/or experimental 
variations. The data were analyzed in triplicate using the 
2−∆∆Ct equation.8,17,19
∆∆Ct = (Ct β-ARs – Ct β-actin)high-fat diet – (Ct β-ARs – Ct β-actin)control  (1)
The mean threshold cycle (Ct) values for both the target 
(β1- and β2-ARs) and internal control (β-actin) genes were 
determined in each sample.
Western blot analysis of β1- and β2-Ar 
proteins
Left ventricles from control (n = 5) and high-fat-fed (n = 5) 
Ossabaw swine were isolated and placed in liquid nitrogen 
and stored at −80°C. Ventricles were homogenized in 
150 µL of buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 
1% Triton X-100 [Sigma-Aldrich, Inc, St Louis, MI], 0.1% 
SDS [sodium dodecyl sulphate], 1 mM EDTA [ethylene 
diamine tetraacetic acid], 1 mM EGTA [ethylene glycol-bis 
(β-aminoethylether)-N,N,N′,N′-tetraacetic acid], 10 µg/mL 
aprotinin, 10 µg/mL leupeptin, 10 µg/mL pepstatin, 5:1000 
phenylmethylsulfonyl fluoride [200 nM], 5:1000 Na3VO4 
[200 nM], and 5:1000 NaF [200 nM]). The homogenates 
were centrifuged at 45,000 rpm for 30 minutes at 4°C. The 
supernatants were collected and used for analysis. Protein 
quantity and quality were determined using the Experion 
Semi-automated Electrophoresis System. Basically, 4 µL 
of denatured protein for each sample was loaded into a 
Pro 260 chip (Experion, Bio-Rad). Equivalent amounts of 
  protein were separated by gel electrophoresis (10% Tris-
HCl   Criterion Precast Gel, Bio-Rad). Proteins were trans-
ferred onto nitrocellulose membrane (0.2 µm, Schleicher 
and Schuell, London, England, UK) by semidry electrob-
lotting (Trans Blot SD, Bio-Rad) at 15 V for 1 hour. The 
nitrocellulose membrane was soaked in 10 mM Tris-HCl 
containing 5% nonfat dry milk (Bio-Rad) and 0.7% poly-
oxyethylene-sorbitan monolaurate (Tween® 20, Promega), 
pH = 7.2, overnight at 4°C to block nonspecific sites. The 
membranes were then incubated with the β1- and β2-AR 
purified   polyclonal antibodies (1:300 dilution in Tris-
buffered saline [TBS] with 5% nonfat dry milk and 0.1% 
Tween 20; Santa Cruz Biotechnology, Santa Cruz, CA) for 
2 hours at room temperature. β-actin receptor antiserum 
was used for internal control (1:3000 dilution in TBS 
with 5% nonfat dry milk and 0.1% Tween 20; Santa Cruz 
  Biotechnology). Blots were washed and incubated with 
donkey anti-goat IgG-HRP   secondary antibody (1:3000 
dilution; Santa Cruz Biotechnology) for 1 hour at room 
temperature. Immunoreactivity was visualized with an 
enhanced chemiluminescence Western blotting detection 
kit (Amersham ECL™ GST Western Blotting Detection 
Kit, GE Healthcare, Little Chalfont, UK). Quantitative 
assessment of band densities was performed by scanning 
densitometry.
statistical analyses
Data are expressed as mean ± standard error of the mean. 
Statistical testing was directed to detect overall treatment 
effects. An unpaired t-test was used to compare differences 
in bodyweight, plasma sample and hemodynamic data, and 
specific β1- and β2-AR gene and protein expression between 
the control and high-fat-fed animals.
Results
Phenotype of Ossabaw swine
Chronic high-fat feeding caused many common features 
of the metabolic syndrome in Ossabaw swine: animals 
were obese, hyperinsulinemic, dyslipidemic, hypercholes-
trolemic, and hypertensive (Figure 1 and Table 1). In con-
trast, control (normal-fed) animals were lean, normotensive, 
normoglycemic, and had normal lipid profiles.
hemodynamic parameters
A high-fat diet of 50 weeks induced many common features 
of the prediabetic metabolic syndrome. Systolic, diastolic, 
and mean arterial blood pressures and heart rate were 
  significantly elevated in high-fat-fed Ossabaw swine, com-
pared with their lean controls (Figure 1).International Journal of General Medicine 2011:4
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Figure 2 Using real-time PCR, no significant changes in mRNA of β1- and β2-Ars were detected in left ventricle obtained from high-fat-fed Ossabaw swine when compared 
with controls. (A) Melt curve graph for sYBr®-β1- and β2-Ars and β-actin. (B) Pcr amp/cycle graph for β1- and β2-Ars and β-actin.
Abbreviations: CF, curve fit; AR, adrenoceptor; PCR, polymerase chain reaction; RFU, relative fluorescence units; CT, mean cycle threshold value.
Table 1 Chronic high-fat feeding significantly increased fasting 
blood  glucose,  fasting  insulin  level,  total  cholesterol,  and 
triglyceride levels
Control group  
(n = 7)
High-fat-diet   
group (n = 9)
Fasting blood glucose (mg/dL)    79 ± 3   106 ± 9a
Fasting insulin level (µU/mL)   4.8 ± 1.6   12.1 ± 4.6a
Total cholesterol level (mg/dL) 57.0 ± 5.5 165.6 ± 8.3a
Total triglyceride level (mg/dL) 24.7 ± 3.2   49.6 ± 2.9a
Note: aP , 0.05 versus control.
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mrnA and protein expression of cardiac 
β1- and β2-Ars in control and chronically 
high-fat-fed Ossabaw swine
The quality of total RNA was determined by using distinct 18S 
and 28S ribosomal RNA fragments in the electropherogram. 
All samples used for analysis were of the same quality 
and quantity demonstrated in microfluidic-based LabChip 
sample wells. However, real-time PCR revealed no significant 
alterations in ventricular β1- and β2-AR mRNA expression 
in high-fat-fed Ossabaw swine compared with their controls 
(Figure 2). Pro260 chip–automated gel electrophoresis was 
used for determining protein quality and quantity (Figure 3). 
Western blot analysis demonstrated a significant decrease in 
ventricular β1- and β2-AR protein expression (19.86% and 
22.6%, respectively) (Figure 4).
Discussion
The purpose of the present investigation was to examine the 
hypothesis that metabolic syndrome could alter expression 
of cardiac β1,2-AR subtypes. Syndrome X, the deadly quartet, 
insulin resistance syndrome, and metabolic syndrome have 
been described previously and have many features of obesity 
and insulin deficiency in humans. We selected high-fat-fed 
Ossabaw swine as a cardiometabolic risk model because it 
is a very well established research model on the cardiovas-
cular system. Ossabaw swine have applicability to human 
cardiometabolic syndrome and have a “thrifty genotype.” If 
they are fed with a high-fat diet for a long time, they develop 
metabolic syndrome.
Chronic high-fat feeding caused many common features of 
the metabolic syndrome in Ossabaw swine, ie, obesity, hyper-
insulinemia, dyslipidemia, hypercholestrolemia, and hyper-
tension, compared with the lean control group (Table 1 and 
Figure 1). We found that their systolic,   diastolic, and mean 
arterial blood pressures and heart rate were significantly 
elevated compared with their lean controls (Figure 1). This 
hemodynamic picture indicates that they have a hyperdynamic 
circulatory state, which demonstrates increased sympathetic 
system activity. These findings were very consistent with 
our previous studies, where acute high-fat feeding triggered 
positive-feedback mechanisms to correct hemodynamic International Journal of General Medicine 2011:4
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Figure 3 Protein gel electrophoresis (chip). (A) Pro260 chip automated gel electrophoresis. Five controls and five high-fat-diet left ventricle protein gel electrophoresis 
obtained from Ossabaw swine heart. Basically, 4 µL of denatured protein for each sample was loaded into a Pro260 experion chip (Bio-rad). (B) experion Pro260 Ladder 
electropherogram. The Pro260 ladder contains nine proteins ranging from 10–260 kDa as well as 1.2 kDa lower marker. (C and D) sample electropherograms obtained 
from control (C) and high-fat-fed (D) left ventricle protein extractions. Left ventricles were homogenized in radio immunoprecipitation assay lysis buffer (which included 
phenylmethylsulfonyl fluoride and Na orthovanadate solutions as well as protease inhibitor cocktail). The homogenates were centrifuged at 45,000 rpm for 30 minutes at 
4°c. The supernatants were collected and used for analysis.
260.0
150.0
100.0
75.0
50.0
37.0
25.0
20.0
10.0
1.2
Ladder
Controls
P
r
o
 
2
6
0
 
(
k
D
a
)
High-fat diet
1234567891 0
A
800
700
600
500
400
300
200
100
−100
−200
−300
10 20 30 40 50 60
1
3
*
1
2
1
1
1
0
9
8
7
6
1
*
5
4
3
2
0
Time (seconds)
B
F
l
u
o
r
e
s
c
e
n
c
e
Ladder
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
497
cardiac β-Ars expression in metabolic syndrome
imbalances.8,17,18 These cardiovascular risk clusters could 
directly attenuate main cardiovascular function.
Increased sympathetic system activity could cause 
downregulation of cardiac β-ARs and could change their 
secondary and tertiary structures. A persistent hypercat-
echolaminergic state, which is seen in high cardiometabolic 
risk subjects, triggers reversible or irreversible protein 
modifications in cell surface receptors. Both β1 and β2 
subtypes have been shown to functionally coexist in the 
human heart.13–16 The hazardous effects of elevated cat-
echolamine levels are found to be mediated primarily by 
β1-ARs contrary to β2-ARs stimulation, which may be adap-
tive in some cases.13,15,16 β1- and β2-ARs each couple to Gs; 
however, a growing body of recent evidence suggests that 
β2-ARs also couple to inhibitory protein Gi.10,12 In spite of 
these differences, the author and colleagues have previously 
demonstrated that both β1- and β2-AR expression and β1- and 
β2-AR-mediated inotropic and chronotropic responses were 
decreased in chronic diabetic hearts.13–16 There are a number 
of explanations for decreased β-AR expression in metabolic 
syndrome. Systemic hemodynamic alterations, key protein 
modifications, and intrinsic functional changes are major 
factors in attenuating β-AR-dependent cardiac inotropic and 
chronotropic responses.
This study found that chronic high-fat feeding resulted in 
decreased ventricular β1- and β2-AR protein expression, as 
expected. Real-time PCR revealed no significant   alterations 
in ventricular β1- and β2-AR mRNA. These data directly 
demonstrate that downregulation of ventricular β1- and 
β2-ARs is possibly related to constant sympathetic system International Journal of General Medicine 2011:4
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Figure 4 Western blot analysis of β1- and β2-Ars obtained from control and high-
fat-fed Ossabaw swine left ventricles. Western blot analyses revealed a significant 
decrease  in  ventricular  β1-  and  β2-Ars:  19.86%  and  22.6%,  respectively.  signal 
intensities were normalized to concomitant β-actin.
Note: aP , 0.05 versus control.
Abbreviation: Ar, adrenoceptor.
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stimulation. Increased sympathetic system activity stimulates 
β-ARs and elevates intracellular cAMP, thereby activating 
PKA and/or CaMKII.10 Recent evidence demonstrates that 
constant β-ARs stimulation switches the signaling pathway 
from PKA to CaMKII predominance in more chronic stag-
es.12 Activation of the CaMKII pathway instead of PKA as 
well as PKA activity and underlying mechanisms were not 
determined; further experimentation is necessary.
Conclusion
This is the first report in a novel large animal model where 
induction of metabolic syndrome is accompanied by a sig-
nificant reduction in cardiac β1- and β2-AR protein expres-
sion that could contribute to impaired cardiac function.
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